CCSA formed its Scientific Advisory Council (SAC) in 2007 to help keep abreast of scientific developments in the addictions field, to ensure that biomedical and neuroscience learnings are represented in CCSA’s work, and to connect key researchers and clinical experts in the field.
SAC helps CCSA create new partnerships and linkages with academic institutions, and offers an opportunity through its activities to influence policy and practice and to transform clinical and community programs. The council, which meets twice a year, also provides an ongoing environmental scan of emerging trends in clinical treatment and research.
SAC’s recent work includes leadership to support new releases in CCSA’s
Substance Abuse in Canada series.
|Dr. Franco Vaccarino||Chair, Scientific Advisory Council President and Vice-Chancellor || University of Guelph|
|Rita Notarandrea||Co-Chair, Scientific Advisory Council Interim Chief Executive Officer ||Canadian Centre on Substance Abuse|
|Dr. Tony George ||Professor of Psychiatry Medical Director, Complex Mental Illness Program Chief, Schizophrenia Division||Centre for Addiction and Mental Health, University of Toronto|
|Dr. Michael Krausz ||Professor of Psychiatry|| Centre for Health Evaluation and Outcome Sciences, University of British Columbia |
| Dr. Marco Leyton||Professor of Psychiatry|| Department of Psychiatry, McGill University|
|Dr. Sherry Stewart ||Professor of Psychiatry, Psychology, and Community Health and Epidemiology||Department of Psychiatry and Psychology, Dalhousie University|
|Dr. Rachel Tyndale ||Section Head, Pharmacogenetics Professor of Pharmacology, Toxicology and Psychiatry || Centre for Addiction and Mental Health, University of Toronto |
| Dr. Zulfiquar (Zul) Merali||President/CEO & Scientific Director Professor of Medicine and Psychology || Institute of Mental Health Research, University of Ottawa |
Looking for more information about the Scientific Advisory Council?
Complete the form